This groundbreaking achievement opens new horizons in the field of brain-computer interfaces (BCI).
The patient, who had a Neuralink chip placed in his brain, is currently continuing his post-operative recovery process.
We also recall that the company started recruiting humans for its first clinical trial in the fall of 2023 after receiving approval from the US Food and Drug Administration (FDA).
The study was suitable for people with quadriplegia due to cervical spinal cord injury or motor neuron disease (ALS).
The initial goal of Neuralink’s BCI is to enable people to control a computer cursor or keyboard using only their thoughts.
Musk did not disclose details about the procedure or the status of the trial, but noted that “preliminary results show encouraging detection of neural firings.”
Source: Ferra
I am a professional journalist and content creator with extensive experience writing for news websites. I currently work as an author at Gadget Onus, where I specialize in covering hot news topics. My written pieces have been published on some of the biggest media outlets around the world, including The Guardian and BBC News.
